Refeeding Syndrome with Hypoglycemia in a Severely Malnourished Infant

Daiji Takajo1, Natalie Sabzghabaei2

  • 1Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI, USA. dt1449@gmail.com.

Insights

Refeeding syndrome in infants can cause dangerous hypoglycemia. This case highlights the critical need for careful monitoring during nutritional rehabilitation in severely malnourished infants, especially when initiating enteral feeding.

Area of Science:

  • Pediatrics
  • Metabolic Disorders
  • Nutritional Science

Background:

  • Severe malnutrition in infants presents significant clinical challenges.
  • Parental neglect can lead to critical infant malnutrition and associated complications.
  • Refeeding syndrome is a complex metabolic response to nutritional support.

Observation:

  • A 5-month-old infant with severe malnutrition presented with hypoglycemia, bradycardia, bradypnea, and hypothermia.
  • The infant required resuscitation with dextrose-containing intravenous fluids.
  • Refeeding was initiated on day 2 of admission.

Findings:

  • Following refeeding initiation, the infant experienced recurrent hypoglycemia.
  • Electrolyte disturbances including hypophosphatemia, hypomagnesemia, and hypokalemia were observed.
  • Hypoglycemia correlated with the commencement and escalation of enteral feeding, indicating a link to refeeding.

Implications:

  • This case represents the first reported instance of hypoglycemia associated with refeeding syndrome in an infant.
  • Highlights the potential for severe metabolic complications during nutritional rehabilitation in malnourished infants.
  • Emphasizes the importance of vigilant monitoring for hypoglycemia and electrolyte imbalances during infant refeeding protocols.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
735
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.5K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
688
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
645
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K